Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166802 · ClinicalTrials.gov registry record
Development of a Questionnaire to Measure Hypervigilance for Visceral Pain
A clinical trial of Irritable Bowel Syndrome, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 157
- Enrollment target
- 1
- Study location
NCT01166802: Completed study of Irritable Bowel Syndrome, sponsored by University of North Carolina, Chapel Hill.
NCT01166802 is a study of Irritable Bowel Syndrome that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 157 participants, above the 141-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01166802, a study of Irritable Bowel Syndrome, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 157 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to develop and validate a questionnaire (non-invasive technique) to identify patients who are hypervigilant for noxious visceral sensations and who show a lower threshold to report pain. This questionnaire would be useful in studies investigating the role of visceral pain hypervigilance and pain sensitivity in the comorbidity of IBS with other somatic disorders.
Conditions Studied
Study Locations (1)
North Carolina
- UNC Center for Clinical and Translational Research - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-06 |
What the finished NCT01166802 record still lists
NCT01166802 is an observational study that tracks outcomes without assigning an intervention. The registered 157 participants enrollment target is mid-sized for trials with a published cap, above the 141-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (11% higher).
The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT01166802 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01166802 about?
NCT01166802 is a clinical study titled "Development of a Questionnaire to Measure Hypervigilance for Visceral Pain". The aim of this study is to develop and validate a questionnaire (non-invasive technique) to identify patients who are hypervigilant for noxious visceral sensations and who show a lower threshold to report pain. This questionnaire would be useful in studies investigating the role of visceral pain hy...
What is the current status of trial NCT01166802?
This trial is currently completed. The enrollment target is 157 participants. The study started on 2008-02. Estimated completion is 2010-06.
What conditions does trial NCT01166802 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome.
Who is sponsoring clinical trial NCT01166802?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01166802 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01166802's enrollment target sits among peer trials
157 13th of 47 higher than 35 of 47 other Irritable Bowel Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Irritable Bowel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
Psyllium in Pediatric IBS
RECRUITING · Phase 2
-
Mucosal and Microbiota Changes During Acute Campylobacteriosis
RECRUITING
-
GI Alpha-Gal Study
RECRUITING · NA
-
Visible Abdominal Distension
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05052541 · 157 participants · Phase 3
Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
- NCT05076942 · 157 participants · Phase 2
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
- NCT06396598 · 157 participants · NA
Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
- NCT06655246 · 157 participants · Phase 1
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia